Mahmoud M Ibrahim
Overview
Explore the profile of Mahmoud M Ibrahim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
1010
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ibrahim M, Koehler K, Kohler K, Lessl M, Gamalinda M
Drug Discov Today
. 2025 Mar;
30(3):104325.
PMID: 40057114
Many industries face challenges in driving an innovation strategy that sustains value growth and aligns with the company's social responsibility. Bayer is in a unique position as a global diversified...
2.
Kang B, Camps J, Fan B, Jiang H, Ibrahim M, Hu X, et al.
Genome Biol
. 2022 Dec;
23(1):265.
PMID: 36550535
Background: The tumor microenvironment (TME) has been shown to strongly influence treatment outcome for cancer patients in various indications and to influence the overall survival. However, the cells forming the...
3.
Camps J, Noel F, Liechti R, Massenet-Regad L, Rigade S, Gotz L, et al.
Cancer Res
. 2022 Dec;
83(3):363-373.
PMID: 36459564
Significance: The IMMUcan scDB database is an accessible supportive tool to analyze and decipher tumor-associated single-cell RNA sequencing data, allowing researchers to maximally use this data to provide new insights...
4.
Ali M, Ahmed M, Ibrahim M, El Baroudy A, Ali E, Shokr M, et al.
Int J Biometeorol
. 2022 Feb;
66(5):971-985.
PMID: 35149894
The impacts of climate change and possible adaptations to food security are a global concern and need greater focus in arid and semi-arid regions. It includes scenario of Coupled Model...
5.
Shehata T, Ibrahim M, Elsewedy H
Polymers (Basel)
. 2021 Apr;
13(5).
PMID: 33806659
Curcumin is a poorly water-soluble drug that is used for the treatment of inflammations, tumors, wound healing antioxidant and other diseases. In the current manuscript, it is successfully formulated into...
6.
Garcia-Alonso L, Holland C, Ibrahim M, Turei D, Saez-Rodriguez J
Genome Res
. 2021 Apr;
31(4):745.
PMID: 33795376
No abstract available.
7.
Kuppe C, Ibrahim M, Kranz J, Zhang X, Ziegler S, Perales-Paton J, et al.
Nature
. 2020 Nov;
589(7841):281-286.
PMID: 33176333
Kidney fibrosis is the hallmark of chronic kidney disease progression; however, at present no antifibrotic therapies exist. The origin, functional heterogeneity and regulation of scar-forming cells that occur during human...
8.
Tajti F, Kuppe C, Antoranz A, Ibrahim M, Kim H, Ceccarelli F, et al.
Kidney Int Rep
. 2020 Feb;
5(2):211-224.
PMID: 32043035
Introduction: To develop effective therapies and identify novel early biomarkers for chronic kidney disease, an understanding of the molecular mechanisms orchestrating it is essential. We here set out to understand...
9.
Garcia-Alonso L, Holland C, Ibrahim M, Turei D, Saez-Rodriguez J
Genome Res
. 2019 Jul;
29(8):1363-1375.
PMID: 31340985
The prediction of transcription factor (TF) activities from the gene expression of their targets (i.e., TF regulon) is becoming a widely used approach to characterize the functional status of transcriptional...
10.
Ibrahim M, Karabacak A, Glahs A, Kolundzic E, Hirsekorn A, Carda A, et al.
Nat Commun
. 2018 Oct;
9(1):4472.
PMID: 30367057
Divergent transcription from promoters and enhancers is pervasive in many species, but it remains unclear if it is a general feature of all eukaryotic cis regulatory elements. To address this,...